Guardant Health (GH) Enterprise Value (2017 - 2026)

Guardant Health has reported Enterprise Value for 10 years, with the latest figure at -$1.1 billion in Q2 2026.

• Quarterly Enterprise Value fell 67.45% year-over-year to -$1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 67.45% YoY) and the FY2025 annual result came in at -$1.2 billion, down 43.05% from the prior year.
• Enterprise Value advanced to -$1.1 billion in Q2 2026 per GH's latest filing, from -$1.1 billion in the prior quarter.
• Over five years, Enterprise Value peaked at -$580.0 million in Q3 2025 and troughed at -$1.2 billion in Q2 2023.
• A 5-year average of -$957.5 million and a median of -$960.2 million in 2022 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2022 and 2026: Enterprise Value soared 50.72% in 2022, then slumped 67.45% in 2026.
• Over 5 years, Enterprise Value stood at -$1.0 billion in 2022, then slipped by 15.57% to -$1.2 billion in 2023, then gained by 28.12% to -$840.0 million in 2024, then tumbled by 43.05% to -$1.2 billion in 2025, then climbed by 12.33% to -$1.1 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$1.1 billion, -$1.1 billion, and -$1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.